A hybrid
cell line resulting from the fusion of a specific
antibody -producing spleen cell (lymphocyte) with a myeloma cell, which has the growth characteristics
of the myeloma component and the
antibody-secreting characteristics of the lymphocyte, and will multiply to become a source
of pure
monoclonal antibody.
Source:
PAC, 1992, 64, 143
(Glossary for chemists of terms used in biotechnology (IUPAC Recommendations 1992))
on page 156
Cite as:
IUPAC. Compendium of Chemical Terminology, 2nd ed. (the "Gold Book"). Compiled by
A. D. McNaught and A. Wilkinson. Blackwell Scientific Publications, Oxford (1997).
XML on-line corrected version: http://goldbook.iupac.org (2006-) created by M. Nic,
J. Jirat, B. Kosata; updates compiled by A. Jenkins. ISBN 0-9678550-9-8.
https://doi.org/10.1351/goldbook.
